PERNIX THERAPEUTICS HLDGS IN's ticker is PTX and the CUSIP is 71426V108. A total of 105 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $0 | -100.0% | 49 | -98.8% | 0.00% | – |
| Q1 2016 | $4,000 | -99.9% | 4,176 | -99.6% | 0.00% | -100.0% |
| Q4 2015 | $3,083,000 | +20.7% | 1,045,279 | +29.3% | 0.00% | 0.0% |
| Q3 2015 | $2,555,000 | -47.3% | 808,447 | -1.3% | 0.00% | -33.3% |
| Q2 2015 | $4,852,000 | -44.5% | 819,461 | +0.2% | 0.01% | -40.0% |
| Q1 2015 | $8,739,000 | +7.7% | 817,485 | -5.4% | 0.01% | +11.1% |
| Q4 2014 | $8,116,000 | -21.2% | 864,340 | -35.5% | 0.01% | -25.0% |
| Q3 2014 | $10,295,000 | -10.8% | 1,340,470 | +4.3% | 0.01% | -7.7% |
| Q2 2014 | $11,546,000 | – | 1,285,763 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 2,484,649 | $7,330,000 | 8.59% |
| Avoro Capital Advisors LLC | 5,144,916 | $15,178,000 | 5.23% |
| Broadfin Capital, LLC | 6,090,829 | $17,968,000 | 1.10% |
| Aisling Capital LLC | 2,010,000 | $5,930,000 | 1.02% |
| Healthcare Value Capital, LLC | 150,000 | $443,000 | 0.73% |
| ACUTA CAPITAL PARTNERS, LLC | 434,300 | $1,281,000 | 0.61% |
| WALL STREET ASSOCIATES | 696,300 | $2,054,000 | 0.58% |
| SEARLE & CO. | 172,500 | $500,000 | 0.48% |
| Elk Creek Partners, LLC | 2,253,667 | $6,648,000 | 0.47% |
| KOPP INVESTMENT ADVISORS LLC | 315,293 | $931,000 | 0.46% |